Patent details
EP3362068 Title: COMBINATION ANTIBACTERIAL COMPOSITION AND SHORT-COURSE ANTIBACTERIAL REGIMEN COMPRISING LINEZOLID, BEDAQUILINE AND PRETOMANID
Basic Information
- Publication number:
- EP3362068
- PCT Application Number:
- US2016055414
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP168559730
- PCT Publication Number:
- WO2017066053
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION ANTIBACTERIAL COMPOSITION AND SHORT-COURSE ANTIBACTERIAL REGIMEN COMPRISING LINEZOLID, BEDAQUILINE AND PRETOMANID
- French Title of Invention:
- COMPOSITION D'UN MÉLANGE D'AGENTS ANTIBACTÉRIENS ET SCHÉMA DE TRAITEMENT ANTIBACTÉRIEN DE COURTE DURÉE COMPRENANT DU LINÉZOLIDE, DE LA BÉDAQUILINE ET DU PRETOMANID
- German Title of Invention:
- ANTIBAKTERIELLE KOMBINATIONSZUSAMMENSETZUNG UND ANTIBAKTERIELLER THERAPIEPLAN MIT KURZEM VERLAUF MIT LINEZOLID, BEDAQUILIN UND PRETOMANID
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 19/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 29/01/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 20/12/2023
- Unitary Effect Registration Date:
- 29/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 05/10/2016
- Grant date:
- 20/12/2023
- EP Publication Date:
- 22/08/2018
- PCT Publication Date:
- 20/04/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/12/2023
- EP B1 Publication Date:
- 20/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 05/10/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/12/2023
- Name:
- The Global Alliance for TB Drug Development, Inc.
- Address:
- 40 Wall Street 24th Floor, New York, NY 10005, United States (US)
Inventor
1
- Name:
- MDLULI, Khisimuzi, Jr.
- Address:
- United States (US)
2
- Name:
- MENDEL, Cari, M.
- Address:
- United States (US)
3
- Name:
- NUERMBERGER, Eric
- Address:
- United States (US)
Priority
- Priority Number:
- 201562241280 P
- Priority Date:
- 14/10/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/47; A61K 31/535; C07D 215/227; C07D 263/20; C07D 413/02; C07D 498/04; A61P 31/04; A61K 31/4965; A61K 31/5365; A61K 31/5377; C07D 241/24;
Publication
European Patent Bulletin
1
- Issue number:
- 202351
- Publication date:
- 20/12/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202402
- Publication date:
- 10/01/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|